References:
  1. Sullivan KE, Mullen CA, Blaese RM, Winkelstein JA. A multiinstitutional survey of the Wiskott-Aldrich syndrome. J Pediatr . 1994;125(6 Pt 1):876-885. doi:10.1016/s0022-3476(05)82002-5
  2. Burroughs LM, Petrovic A, Brazauskas R, et al. Excellent outcomes following hematopoietic cell transplantation for Wiskott-Aldrich syndrome: a PIDTC report. Blood . 2020;135(23):2094-2105. doi:10.1182/blood.2019002939
  3. Prockop SE, Hasan A, Koehne G, et al. Third Party Donor Derived CMV Specific T Cells for the Treatment of Refractory CMV Viremia and Disease after Hematopoietic Stem Cell Transplant. Blood . 2014;124(21):184-184. doi:10.1182/blood.V124.21.184.184
  4. Mori T, Kikuchi T, Koh M, et al. Cytomegalovirus retinitis after allogeneic hematopoietic stem cell transplantation under cytomegalovirus antigenemia-guided active screening. Bone Marrow Transplant . 2021;56(6):1266-1271. doi:10.1038/s41409-020-01176-8
  5. Crippa F, Corey L, Chuang EL, Sale G, Boeckh M. Virological, Clinical, and Ophthalmologic Features of Cytomegalovirus Retinitis after Hematopoietic Stem Cell Transplantation. Clin Infect Dis . 2001;32(2):214-219. doi:10.1086/318447
  6. Feuchtinger T, Opherk K, Bethge WA, et al. Adoptive transfer of pp65-specific T cells for the treatment of chemorefractory cytomegalovirus disease or reactivation after haploidentical and matched unrelated stem cell transplantation. Blood . 2010;116(20):4360-4367. doi:10.1182/blood-2010-01-262089
  7. Nelson AS, Heyenbruch D, Rubinstein JD, et al. Virus-specific T-cell therapy to treat BK polyomavirus infection in bone marrow and solid organ transplant recipients. Blood Adv. 2020;4(22):5745-5754. doi:10.1182/bloodadvances.2020003073
  8. Pergam SA, Xie H, Sandhu R, et al. Efficiency and risk factors for CMV transmission in seronegative hematopoietic stem cell recipients.Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant . 2012;18(9):1391-1400. doi:10.1016/j.bbmt.2012.02.008
  9. Vassallo F, Nuzzi R, Cattani I, et al. CMV retinitis in a stem cell transplant recipient treated with foscarnet intravitreal injection and CMV specific immunoglobulins. Ther Adv Hematol . 2020;11:204062072097565. doi:10.1177/2040620720975651
  10. Bertaina A, Merli P, Rutella S, et al. HLA-haploidentical stem cell transplantation after removal of αβ+ T and B cells in children with nonmalignant disorders. Blood . 2014;124(5):822-826. doi:10.1182/blood-2014-03-563817
  11. Elfeky R, Lazareva A, Qasim W, Veys P. Immune reconstitution following hematopoietic stem cell transplantation using different stem cell sources. Expert Rev Clin Immunol. (2019) 15:735–51. doi: 10.1080/1744666x.2019. 1612746
  12. Cwynarski K, Ainsworth J, Cobbold M, et al. Direct visualization of cytomegalovirus-specific T-cell reconstitution after allogeneic stem cell transplantation. Blood . 2001;97(5):1232-1240. doi:10.1182/blood.v97.5.1232
  13. Orellana J, Teich SA, Winterkorn JS, et al. Treatment of cytomegalovirus retinitis with ganciclovir (9-[2-hydroxy-1-(hydroxymethyl) ethoxymethyl] guanine (BW B759U).Br J Ophthalmol . 1988;72(7):525-529. doi:10.1136/bjo.72.7.525
  14. Bollard CM, Heslop HE. T cells for viral infections after allogeneic hematopoietic stem cell transplant. Blood . 2016;127(26):3331-3340. doi:10.1182/blood-2016-01-628982
  15. Houghtelin A, Bollard CM. Virus-Specific T Cells for the Immunocompromised Patient. Front Immunol . 2017;8:1272. doi:10.3389/fimmu.2017.01272
  16. Qian C, Wang Y, Reppel L, et al. Viral-specific T-cell transfer from HSCT donor for the treatment of viral infections or diseases after HSCT. Bone Marrow Transplant . 2018;53(2):114-122. doi:10.1038/bmt.2017.232
  17. Gupta MP, Koenig LR, Doubrovina E, et al. Ocular Outcomes after Treatment of Cytomegalovirus Retinitis Using Adoptive Immunotherapy with Cytomegalovirus-Specific Cytotoxic T Lymphocytes. Ophthalmol Retina . 2021;5(9):838-849. doi:10.1016/j.oret.2021.04.009
  18. Seo S, Smith C, Fraser C, et al. Adoptive T-cell therapy for pediatric cytomegalovirus-associated retinitis. Blood Adv . 2019;3(11):1774-1777. doi:10.1182/bloodadvances.2019000121
  19. Wang X, Xu Z, Miao CH. Current clinical evidence on the effect of general anesthesia on neurodevelopment in children: an updated systematic review with meta-regression. PLoS One . 2014;9(1):e85760. Published 2014 Jan 20. doi:10.1371/journal.pone.0085760
  20. Falavarjani KG, Nguyen QD. Adverse events and complications associated with intravitreal injection of anti-VEGF agents: a review of literature. Eye Lond Engl . 2013;27(7):787-794. doi:10.1038/eye.2013.107